Global Proteomics Market to Reach $65.3 Billion by 2030
The global market for Proteomics estimated at US$30.2 Billion in the year 2022, is projected to reach a revised size of US$65.3 Billion by 2030, growing at a CAGR of 10.1% over the analysis period 2022-2030. Reagents, one of the segments analyzed in the report, is projected to record 10% CAGR and reach US$48.2 Billion by the end of the analysis period. Growth in the Instruments segment is estimated at 11% CAGR for the next 8-year period.
Proteomics has emerged as a crucial research tool in the battle against COVID-19. The pressing need for diagnostics and therapeutics for COVID-19 has highlighted the dynamic role of proteomics in gaining insights into the virus and facilitating drug discovery.
Proteomics plays a significant role in enabling the development of potent antiviral agents and improved vaccines against COVID-19. Proteomics labs are actively exploring therapeutic options and diagnostic development related to the virus.
Proteomics encompasses the study of proteins, proteome, and their data types and characteristics. It has its genesis in important milestones and has various applications in fields such as medicine, biology, and drug discovery. The global proteomics market is competitive, with various key competitors vying for market share, and their competitive presence varies from strong to niche or trivial.
Despite its promising role, proteomics faces challenges such as sparse and difficult-to-measure data, the need to democratize proteomics, absence of high-profile projects to stimulate interest, creating novel experimental design, lack of commercialization of high throughput techniques, and a lack of necessary technical skillset.
The U.S. Market is Estimated at $11.5 Billion, While China is Forecast to Grow at 12.8% CAGR
The Proteomics market in the U.S. is estimated at US$11.5 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$6.5 Billion by the year 2030 trailing a CAGR of 12.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.9% and 9.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.7% CAGR.
Special discussions on the global economic climate and market sentiment
Coverage on global competitiveness and key competitor percentage market shares
Market presence analysis across multiple geographies - Strong/Active/Niche/Trivial
Access to digital archives and trademarked research platform
Complimentary updates for one year
Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes
MARKET TRENDS & DRIVERS
Proteomics Profiling to Expedite Drug Discovery
Other Applications of Proteomics in Drug Discovery
New Proteomics Technique to Aid Drug Screening & Biomarker Discovery
Diseases as a Major Cause of Deaths Worldwide Brings to Fore the Growing Importance of New Breakthroughs in Proteomics-Based Technologies: Top Global Causes of Death (In Millions) by Type of Disease for the Years 2000 and 2019
Global Drug Discovery Market by Segment: 2020
Growing Interest in Personalized Medicine to Drive Market Growth
Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
Oncology: A Key Focus Area for Proteomics
Global Breakdown of Total Number of Cancer Cases by Type: 2020
Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
Proteomic Approaches Gain Prominence in Cancer Drug Discovery
Proteomics Technologies Used in Cancer Drug Discovery and Development
Role of Proteomics in Oncology Biomarker Discovery
List of FDA-approved Protein Biomarkers for Cancer
Advancements in Proteomics Bring Biomarkers into Limelight
Different Types of MS-Based Proteomic Discovery Techniques for Biomarkers
Affinity-and-Antibody-Based MS Techniques
CE-MS Technology: An Emerging Technology for Discovery of Biomarkers
Protein Microarrays: A Novel Tool for the Development of Pharmaceuticals
Protein Microarray Formats
New Technologies Expand Application of Proteomics
DIA Technique for Protein Discovery
AI and Machine Learning Address Shortcomings of Traditional Equipment in Effectively Identifying Protein Patterns
Bioinformatics Tools along with Proteomics Accelerate the Process of Pathway Prediction
Map of COVID-19 and Human Protein Interactions Reveals Drug Targets
Single-Cell Proteomics Offers a Better Understanding of Cellular Identity
Metalloproteomics: A Rapidly Evolving Field
Post-translational Modification of Proteins Increases Functional Diversity of Proteome
Pharmacoproteomics Holds Significant Prospects in Precision Medicine
Increasing Prominence of Nanoproteomics Widens Opportunities
Global Proteomics Sample Preparation Market
Management of Data in Proteomics Research Poses a Big challenge
Role of Contract Research Organizations to Increase in Proteomics
About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
The "Smart Fabrics: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
Global Smart Fabrics Market to Reach $20.6 Billion by 2030The global market for Smart Fabrics estimated at US$4.5 Billion in the year...
SMX (Security Matters) PLC , an innovative company specializing in digitization of physical objects to foster a circular and closed loop economy, in seeking to continuously enhance its core capabilities, today announced the appointment of Ms. Ofira...
Barnes & Noble Education, Inc. , , a leading solutions provider for the education industry, today announced that on February 27, 2024 it received a notice (the "Notice") from the New York Stock Exchange (the "NYSE") indicating that the Company is no...
Solar Alliance Energy Inc. (?Solar Alliance' or the ?Company') , a leading solar energy solutions provider focused on the commercial and industrial solar sector, announces that it intends to settle a total of $165,000 (the "Debt") of accrued...
Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Amplitude, Inc. ("Amplitude" or the "Company") .
Class Period: September 21, 2021 ? February...
Prologis, Inc. , the global leader in logistics real estate, today announced that Tim Arndt, chief financial officer, will present at the Raymond James & Associates' 45th Annual Institutional Investors Conference at the JW Marriott Grande Lakes in...